Blasticidin S HCl solution is supplied ready to use at 10 mg/mL in HEPES Buffer and Sterile Filtered. Blasticidin S is a nucleoside antibiotic isolated from Streptomyces griseochromogenes which inhibits protein synthesis in both prokaryotic and eukaryotic cells. Blasticidin S HCl solution inhibits peptide bond formation by the ribosome. Resistance is conferred by expression of one of two Blasticidin S deaminase genes: BSD from Aspergillus terreus or bsr from Bacillus cereus. These deaminases convert Blasticidin S to a nontoxic deaminohydroxy derivative.
Blasticidin S is used for the prevention of contamination of cell cultures. The recommended working concentration ranges from 1–20 µg/mL depending on the cell line.
Blasticidin S may also be used as a bacterial selection antibiotic in the concentration range of 50–100 µg/mL. To maintain the activity of Blasticidin S for selection purposes, the salt content of the LB medium must remain low (<90 mM) and the pH should not exceed 7.0.
1. Yamaguchi, H., Yamamoto, C. and Tanaka, N. 1965. Inhibition of protein synthesis by blasticidin S. I. Studies with cell-free systems from bacterial and mammalian cells. J. Biochem. 57(5): 667-677. PMID: 4953866
2. Izumi, M., Miyazawa, H., Kamakura, T., Yamaguchi, I., Endo, T. and Hanaoka, F. 1991. Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp. Cell Res. 197(2): 229-233. PMID: 1720391
3. Kimura, M., Takatsuki, A. and Yamaguchi, I. 1994. Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells. Biochim. Biophys. Acta. 1219(3): 653-659. PMID: 7948022
4. Kim, H., Ishidate, T., Ghanta, K.S., Seth, M., Conte, D., Shirayama, M. and Mello, C.C. 2014. A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics. 197(4): 1069-1080. PMID: 24879462
See how others have used Blasticidin S HCl solution (CAS 3513-03-9). Click on the entry to view the PubMed entry .
PMID: # 30838870 Wu, M.|Feng, Y.|Ye, GX.|Han, YC.|Wang, SS.|Ni, HF.|Wang, FM.|Gao, M.|Lv, LL.|Liu, BC.| et al. 2019. Am. J. Physiol. Renal Physiol. 316: F1006-F1015.
PMID: # 30881116 Chiang, KC.|Huang, ST.|Wu, RC.|Huang, SC.|Yeh, TS.|Chen, MH.|Hsu, JT.|Chen, LW.|Kuo, SF.|Chueh, HY.|Juang, HH.|Hung, SI.|Yeh, CN.|Pang, JS.| et al. 2019. Cancer Manag Res. 11: 1893-1905.
PMID: # 30034634 Barone, G.|Arora, A.|Ganesh, A.|Abdel-Fatah, T.|Moseley, P.|Ali, R.|Chan, SY.|Savva, C.|Schiavone, K.|Carmell, N.|Myers, KN.|Rakha, EA.|Madhusudan, S.|Collis, SJ.| et al. 2018. Oncotarget. 9: 29508-29524.
PMID: # 30538136 Thwaites, DT.|Carter, C.|Lawless, D.|Savic, S.|Boyes, JM.| et al. 2018. Blood.
PMID: # 31576091 World J. Gastroenterol. 25: 5434-5450.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.